Nature's endless wonder: unexpected motherhood after pediatric allogeneic stem cell transplantation and severe late effects.
Chronic graft versus host disease
Fertility
Hypogonadism
Late effects
Pregnancy
Journal
Wiener klinische Wochenschrift
ISSN: 1613-7671
Titre abrégé: Wien Klin Wochenschr
Pays: Austria
ID NLM: 21620870R
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
22
06
2019
accepted:
17
03
2020
pubmed:
9
4
2020
medline:
18
11
2020
entrez:
9
4
2020
Statut:
ppublish
Résumé
Infertility and endocrine late effects (LE) are common sequelae after pediatric allogeneic hematopoietic stem cell transplantation (HSCT) after myeloablative conditioning. Nevertheless, the individual risk for these LE is not always easy to predict and therefore these issues are of ongoing interest to the clinical research community dealing with HSCT aftercare. This article describes the case of a young woman who received polychemotherapy and total body irradiation (TBI) containing conditioning for HSCT for a relapsed anaplastic large cell lymphoma (ALCL). She developed severe sclerotic chronic graft-versus-host disease (GVHD) with irreversible joint contractures and multiorgan involvement, requiring long-term multimodal immunosuppressive treatment. Subsequently showing a considerable number of LE including hypergonadotropic hypogonadism, she accepted that infertility would be quite likely. Her courageous personal life planning included part-time working and a partnership but not motherhood. This article reports the unexpected and spontaneous pregnancy and the extreme preterm birth of a surprisingly adequately developing child.
Identifiants
pubmed: 32266465
doi: 10.1007/s00508-020-01642-9
pii: 10.1007/s00508-020-01642-9
pmc: PMC7174256
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
210-214Références
Nature. 2004 Mar 11;428(6979):145-50
pubmed: 15014492
Endocr J. 2008 Dec;55(6):1055-63
pubmed: 18719293
Oncol Res. 2010;18(11-12):607-15
pubmed: 20939437
Hum Reprod. 2009 Apr;24(4):982-90
pubmed: 19153092
Hum Reprod. 1992 Nov;7(10):1342-6
pubmed: 1291557
Dtsch Arztebl Int. 2015 Jan 23;112(4):51-8
pubmed: 25797423
J Clin Oncol. 1988 May;6(5):813-8
pubmed: 3130466
Acta Paediatr Suppl. 1995 Sep;411:57-61; discussion 62
pubmed: 8563071
J Natl Cancer Inst Monogr. 2005;(34):25-7
pubmed: 15784817
Cancer Treat Rev. 1980 Sep;7(3):141-52
pubmed: 7004638
Acta Obstet Gynecol Scand. 2018 May;97(5):587-590
pubmed: 29344946
J Clin Oncol. 2009 Feb 20;27(6):897-903
pubmed: 19139435
Curr Oncol Rep. 2018 Aug 3;20(9):74
pubmed: 30074106
Anesth Analg. 2015 Jun;120(6):1337-51
pubmed: 25988638
J Pediatr. 1997 Feb;130(2):210-6
pubmed: 9042122
Med Pediatr Oncol. 1999 May;32(5):366-72
pubmed: 10219339
J Cancer Surviv. 2014 Dec;8(4):548-54
pubmed: 24810980
Eur J Endocrinol. 2017 Sep;177(3):G1-G70
pubmed: 28705803
Clin Pediatr Endocrinol. 2016 Oct;25(4):119-126
pubmed: 27780981
Ann Rheum Dis. 2010 Feb;69(2):458-61
pubmed: 19336420
Bone Marrow Transplant. 2012 Feb;47(2):271-6
pubmed: 21478918
Biol Blood Marrow Transplant. 2011 Dec;17(12):1725-38
pubmed: 22005649
Am J Obstet Gynecol. 2002 Oct;187(4):1070-80
pubmed: 12389007
Lancet. 2001 Jul 28;358(9278):271-6
pubmed: 11498213
J Pediatr. 2008 Feb;152(2):289-90
pubmed: 18206705
Blood. 2005 Feb 1;105(3):948-58
pubmed: 15486066